BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 18415960)

  • 1. FDA notifications. FDA approves NDA for Lexiva.
    AIDS Alert; 2007 Dec; 22(12):142. PubMed ID: 18415960
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA notifications. FDA approves new formulation of Lexiva.
    AIDS Alert; 2007 Aug; 22(8):90-1. PubMed ID: 17768778
    [No Abstract]   [Full Text] [Related]  

  • 3. Lower dose of ritonavir approved for use with fosamprenavir.
    Sax PE
    AIDS Clin Care; 2007 Dec; 19(12):106. PubMed ID: 18399004
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA approves Lexiva.
    IAPAC Mon; 2003 Nov; 9(11):280. PubMed ID: 14989187
    [No Abstract]   [Full Text] [Related]  

  • 5. Four posters add to our knowledge of Lexiva.
    Proj Inf Perspect; 2008 Dec; (47):7-8. PubMed ID: 19227558
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-HIV agents. Saquinavir with fosamprenavir.
    TreatmentUpdate; 2004; 16(3):9. PubMed ID: 17219609
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA grants approval to fosamprenavir calcium.
    AIDS Alert; 2004 Jan; 19(1):11-2. PubMed ID: 14974421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA approves new dosing for amprenavir and ritonavir combination.
    AIDS Treat News; 2002 Mar; (378):6-7. PubMed ID: 11965920
    [No Abstract]   [Full Text] [Related]  

  • 9. [Maintaining independence. New protease inhibitor receives drug approval recommendation].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():84-5. PubMed ID: 15373062
    [No Abstract]   [Full Text] [Related]  

  • 10. Agenerase approved by FDA.
    Gaylord G
    Posit Living; 1999 May; 8(4):6. PubMed ID: 12492061
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA notifications. FDA OKs new pediatric dosing for darunavir.
    AIDS Alert; 2009 Feb; 24(2):22-4. PubMed ID: 19222149
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA approves darunavir.
    AIDS Patient Care STDS; 2008 Dec; 22(12):1021-2. PubMed ID: 19097261
    [No Abstract]   [Full Text] [Related]  

  • 13. Fosamprenavir: a new PI option. Interview by Craig Sterritt.
    Nadler J
    IAPAC Mon; 2004 Feb; 10(2):50-2. PubMed ID: 15106520
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA notifications. FDA approves new dosing for Kaletra.
    AIDS Alert; 2010 Jun; 25(6):70-1. PubMed ID: 20623833
    [No Abstract]   [Full Text] [Related]  

  • 15. Lexiva (fosamprenavir) approved.
    AIDS Treat News; 2003 Oct; (395):2. PubMed ID: 14666909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA notifications. Potential serious effect of combination saquinavir-ritonavir.
    AIDS Alert; 2010 Apr; 25(4):45-6. PubMed ID: 20564774
    [No Abstract]   [Full Text] [Related]  

  • 17. Fosamprenavir calcium plus ritonavir for HIV infection.
    Torres HA; Arduino RC
    Expert Rev Anti Infect Ther; 2007 Jun; 5(3):349-63. PubMed ID: 17547501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDA approves an AIDS drug from Vertex. Food and Drug Administration.
    Newsline People AIDS Coalit N Y; 1999; ():32. PubMed ID: 11367345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA notifications. FDA approves new Kaletra formulation.
    AIDS Alert; 2005 Dec; 20(12):142-3. PubMed ID: 16400722
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA notifications. New 600 mg tablet strength for darunavir is approved by FDA.
    AIDS Alert; 2008 Apr; 23(4):47. PubMed ID: 19253456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.